You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

busulfan

Showing 51 - 75 of 361
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia (AML), Acute Lymphoid Leukemia (ALL), MDS (MDS) Trial in New York (other, radiation, drug)

Recruiting
  • Acute Myeloid Leukemia (AML)
  • +2 more
  • Personalized rATG (P-rATG)
  • +7 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Aug 31, 2022

AIDS-related Non-Hodgkin Lymphoma, AIDS-related Plasmablastic Lymphoma, AIDS-related Primary Effusion Lymphoma Trial in Duarte

Active, not recruiting
  • AIDS-related Non-Hodgkin Lymphoma
  • +3 more
  • busulfan
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Feb 17, 2022

Inherited Immune Deficiencies Trial run by the NIAID (Campath 1H, Busulfan, Horse Anti-human Thymocyte Globulin (h-ATG))

Completed
Has Results
  • Inherited Immune Deficiencies
  • Campath 1H
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Apr 20, 2021

Acute Myeloid Leukemia, Myelodysplastic Syndrome, Chronic Myeloid Leukemia Trial in Houston (Clofarabine, Busulfan, Fludarabine)

Completed
Has Results
  • Acute Myeloid Leukemia
  • +2 more
  • Houston, Texas
    UT MD Anderson Cancer Center
Jan 6, 2021

Neuroblastoma Trial in Guangzhou (Anti Thymocyte Globulin, Fludarabine, Cyclophosphamide injection)

Not yet recruiting
  • Neuroblastoma
  • Anti Thymocyte Globulin
  • +10 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Jun 29, 2022

Hematologic Disorders, Hemoglobinopathies, Immunodeficiencies Trial in Minneapolis (drug, radiation, biological)

Recruiting
  • Hematologic Disorders
  • +2 more
  • Busulfan
  • +4 more
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Jul 12, 2021

Hematological Malignancies Trial in Philadelphia (radiation, drug, genetic)

Recruiting
  • Hematological Malignancies
  • Total Body Irradiation
  • +6 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Feb 4, 2022

Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell Trial in China (Chidamide, Cladribine, Gemcitabine)

Recruiting
  • Lymphoma, Large B-Cell, Diffuse
  • Lymphoma, T-Cell
  • Deyang, Deyang, China
  • +10 more
Jul 21, 2022

High Risk Acute Myeloid Leukemia, Allogeneic Hematopoeitic Stem Cell Transplantation Trial in Shanghai (Cladribine, Fludarabine,

Recruiting
  • High Risk Acute Myeloid Leukemia
  • Allogeneic Hematopoeitic Stem Cell Transplantation
  • Shanghai, Shanghai, China
    Shanghai general hospital, Shanghai Jiaotong university school o
Oct 10, 2021

High Risk Acute Myeloid Leukemia, Allogeneic Hematopoeitic Stem Cell Transplantation Trial in Shanghai (Cladribine, Fludarabine,

Recruiting
  • High Risk Acute Myeloid Leukemia
  • Allogeneic Hematopoeitic Stem Cell Transplantation
  • Shanghai, Shanghai, China
    Shanghai general hospital, Shanghai Jiaotong university school o
Oct 10, 2021

Fanconi Anemia Trial in Minneapolis (anti-thymocyte globulin, filgrastim, busulfan)

Completed
Has Results
  • Fanconi Anemia
  • anti-thymocyte globulin
  • +6 more
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Nov 4, 2021

Ewing's Family Tumors, Renal Tumors, Hepatoblastoma Trial in Minneapolis (drug, biological, radiation, procedure)

Recruiting
  • Ewing's Family Tumors
  • +11 more
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Apr 11, 2022

Myelodysplastic Syndrome, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Boston (biological, procedure, drug)

Terminated
Has Results
  • Myelodysplastic Syndrome
  • +2 more
  • GVAX
  • +6 more
  • Boston, Massachusetts
  • +3 more
Jun 30, 2022

Sickle Cell Disease, Beta Thalassemia Trial in New York (Busulfan, Fludarabine, Alemtuzumab)

Active, not recruiting
  • Sickle Cell Disease
  • Beta Thalassemia
  • Busulfan
  • +3 more
  • New York, New York
    Morgan Stanley Children's Hospital, New York-Presbyterian, Colum
Aug 12, 2021

Epidermolysis Bullosa Trial in Minneapolis (drug, radiation, procedure, biological)

Recruiting
  • Epidermolysis Bullosa
  • Minneapolis, Minnesota
    University of Minnesota Masonic Cancer Center and Medical Center
Jan 20, 2022

Sickle Cell Disease Trial in United States (biological, drug, genetic)

Recruiting
  • Sickle Cell Disease
  • Plerixafor
  • +2 more
  • Oakland, California
  • +5 more
Sep 13, 2022

Epidermolysis Bullosa Trial in Aurora, Chicago, New York (Palifermin, Fludarabine, Busulfan)

Terminated
  • Epidermolysis Bullosa
  • Aurora, Colorado
  • +2 more
Aug 13, 2021

Hematological Disease, Immune Deficiencies, Solid Tumors Trial in Rochester (radiation, drug, procedure)

Completed
  • Hematological Disease
  • +5 more
  • Total Body Irradiation 1200 cGy
  • +9 more
  • Rochester, New York
    Wilmot Cancer Institute
Nov 1, 2021

Leukemia, MDS, Childhood Acute Myeloid Leukemia in Remission Trial in Minneapolis (biological, drug, procedure)

Recruiting
  • Leukemia
  • +12 more
  • filgrastim
  • +6 more
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Jan 20, 2022

Severe Combined Immunodeficiency Trial in San Francisco (AProArt, CliniMACS® CD34 Reagent System cell sorter device, Busulfan)

Recruiting
  • Severe Combined Immunodeficiency
  • San Francisco, California
    University of California, San Francisco (UCSF) Children's Hospit
Feb 4, 2022

Stem Cell Transplantation, Leukemia Trial in Houston (Plerixafor, Filgrastim, Fludarabine)

Completed
Has Results
  • Stem Cell Transplantation
  • Leukemia
  • Houston, Texas
    UT MD Anderson Cancer Center
Sep 22, 2020

Adenosine Deaminase Deficiency, Severe Combined Immunodeficiencies (SCID) Trial in London (genetic, other, drug)

Completed
Has Results
  • Adenosine Deaminase Deficiency
  • Severe Combined Immunodeficiencies (SCID)
  • Infusion of autologous EFS-ADA LV CD34+ cells
  • +3 more
  • London, United Kingdom
    Great Ormond Street Hospital for Children NHS Foundation Trust
Aug 20, 2021

Refractory Brain Tumors Trial (Busulfan)

Withdrawn
  • Refractory Brain Tumors
  • Busulfan
  • (no location specified)
Aug 3, 2020

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Leukemia Trial in United States (drug, procedure, other, radiation)

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • +10 more
  • Busulfan
  • +10 more
  • Jacksonville, Florida
  • +5 more
Aug 14, 2023

Acute Leukemia, MDS, T-lymphoblastic Lymphoma Trial (drug, radiation, procedure)

Not yet recruiting
  • Acute Leukemia
  • +6 more
  • (no location specified)
Dec 8, 2021